SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

Regeneron Pharmaceuticals, Inc. REGN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Analyst Price Target

Regeneron Pharmaceuticals, Inc. (REGN) 有 12 个已识别的同行可供比较在 Healthcare 板块. 同行包括 ALNY, APLS, ARWR, BGNE, BMRN, CRSP 等.

REGN 的市值为 $78.5B, 而同行平均市值为 $13.12B. REGN 显著大于其平均同行.

同行与相似公司 — REGN

Alnylam Pharmaceuticals, Inc.

$339.41 +1.92% $45.01B

Apellis Pharmaceuticals, Inc.

$40.85 +0.02% $5.22B

Arrowhead Pharmaceuticals, Inc.

$66.69 +4.55% $9.34B

$184.71 +0.49% $20.21B

BioMarin Pharmaceutical Inc.

$55.47 +1.08% $10.67B

CRISPR Therapeutics AG

$56.86 +3.70% $5.46B

Intercept Pharmaceuticals, Inc.

$19.00 +0.21% $794.69M

ImmunoGen, Inc.

$31.24 +0.02% $8.73B

Incyte Corporation

$97.69 +2.24% $19.44B

Ionis Pharmaceuticals, Inc.

$76.76 +2.41% $12.68B

Krystal Biotech, Inc.

$270.00 +0.97% $7.89B

Madrigal Pharmaceuticals, Inc.

$524.99 -0.13% $12.04B

其他人也在看

Novo Nordisk A/S

Alnylam Pharmaceuticals, Inc.

United Therapeutics Corporation

Incyte Corporation

Ionis Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc.

BioMarin Pharmaceutical Inc.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言